Letter to the editor

DOI: 10.4244/EIJ-D-24-00004

Letter: Cardiovascular outcomes after 2-stent or stepwise provisional techniques for coronary bifurcation lesions

Ahmet Güner1, MD; Ezgi Gültekin Güner1, MD; Fatih Uzun1, MD

We have recently read, with great interest, the article by Bujak et al entitled ‘‘Clinical outcomes following different stenting techniques for coronary bifurcation lesions: a systematic review and network meta-analysis of randomised controlled trials’’1. We thank the authors for their comprehensive and meticulous meta-Âanalysis, which included 24 randomised clinical trials (RCTs; 6,890 patients) comparing the clinical outcomes of different revascularisation strategies for the management of coronary bifurcation lesions (CBLs). However, we believe several major drawbacks need to be addressed.

The reasons for our concern are as follows:

First, several investigators reported that the proximal optimisation technique (POT) was associated with a reduction in major cardiovascular events or stent thrombosis. Potential differences in the use of POT23, regardless of the characteristics of the CBLs and the application of the technique, may have affected the results of the RCTs.

Second, the antiplatelet treatment regimen after bifurcation stenting varied among the RCTs in this meta-analysis. In this meta-analysis, several RCTs included ticagrelor and prasugrel as antiplatelet choices, while most other relatively older studies used clopidogrel and ticlopidine1. A recent network meta-analysis showed that ticagrelor and prasugrel outperform clopidogrel in reducing poor clinical outcomes4. We believe that the selection of a dual antiplatelet agent also requires special analysis for CBLs in this meta-analysis. Therefore, readers may wonder whether a more detailed analysis has been done on this subject.

Third, heterogeneities in the features of CBLs within each of the RCTs in the current meta-analysis are highly variable1. Several RCTs, particularly the DKCRUSH and the DEFINITION trials, included more complex cases such as those described in the DEFINITION criteria, which limited the applicability of the results to the whole patient population.

Fourth, the included RCTs were conducted in the period up to 2022, and since then, there have been significant improvements in secondary prevention, advances in stent design, selection of antiproliferative agents in stents, iterations in bifurcation techniques, and functional testing of lesions. In several RCTs, when >1 technique was used, events were attributed to the bifurcation technique that was most often performed1.

Lastly, arterial access route (radial or femoral) has been reported as a potentially confounding variable in only a limited number of RCTs1. This may prevent comprehensive conclusions regarding the results of treatment strategies.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 20 Number 7
Apr 1, 2024
Volume 20 Number 7
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-23-00044 Oct 23, 2023
Shifting focus in bifurcations
Zimarino M et al
free

10.4244/EIJV7I1A26 May 17, 2011
Tools & Techniques: PCI in coronary bifurcations lesions
Louvard Y and Lefèvre T
free

State-of-the-Art Review

10.4244/EIJ-D-21-01065 Jul 22, 2022
Percutaneous coronary intervention of bifurcation lesions
Hildick-Smith D et al
free
Trending articles
57.8

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
39.45

Clinical research

10.4244/EIJ-D-23-00725 Nov 19, 2023
A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study
Rosseel L et al
free
39.45

Original Research

10.4244/EIJ-D-23-00725 Mar 18, 2024
A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study
Rosseel L et al
free
36

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
35.15

State-of-the-Art

10.4244/EIJ-D-23-00895 Apr 1, 2024
Percutaneous interventions for pulmonary embolism
Finocchiaro S et al
free
28.5

CLINICAL RESEARCH

10.4244/EIJV11I1A6 May 19, 2015
European expert consensus on rotational atherectomy
Barbato E et al
free
22.55

CLINICAL RESEARCH

10.4244/EIJV12I5A93 Aug 5, 2016
Longer pre-hospital delays and higher mortality in women with STEMI: the e-MUST Registry
Benamer H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved